Vol. 1, Number 1
November 1, 2009
cheryl riley, editor & writer
Archives
|
IACM
|
Who's Who
|
What's New
|
Subscribe
|
Contact Us
AAMC Home
AAMC California
AAMC El Dorado County CA
AAMC Idaho
AAMC Kansas
AAMC Oregon
AAMC Washington

The American Academy of Cannabinoid Medicine (AACM)


The American Academy of Cannabinoid Medicine readily recognizes the therapeutic benefits of the cannabis plant because thousands of internationally-conducted scientific studies have clearly indicated that the active ingredients in cannabis are effective in the treatment of a long and growing list of medical disorders.

Founded by physicians in early 2009, the AACM aims to further clinical understanding of the endocannabinoid system, therapeutic use of cannabis and to establish the highest standards for the use of cannabinoids in medicine.

A primary goal of this group is to establish impeccable standards for the practice of cannabis and cannabinoids medicine. The value of their dissemination of scientifically accurate information on the medical use of cannabis is undeniable.

The AACM hopes to return cannabis to its rightful place in the United States Pharmacopeia. Therefore, these physicians practice and promote the highest ethical standards in evaluating, approving or recommending the medical use of cannabis and have developed standards and guidelines to certify doctors who, acting in accordance with state law, wish to recommend cannabis therapy to qualifying patients.

According to the AACM, two key reports, the 1997 House of Lords Science and Technology Committee report on Medicinal Cannabis, and the 1999 Institute of Medicine Report---commissioned and funded by the U.S. Government---are quite credible and have been useful in expanding knowledge of the therapeutic properties of cannabinoids.

Research conducted since the reports were issued has expanded knowledge of the value and action of cannabinoids in clinical situations. Clinical and research knowledge bases, along with extensive experience in treating thousands of patients with cannabis and cannabinoids qualifies the AACM as a major source of information on the clinical aspects of recent research.

The organization aspires to become a peerless resource for medical professionals, licensing agencies and even the media. Members have the experience and clinical knowledge to speak confidently about therapeutic applications of cannabinoids and cannabis, and are deeply committed to educating other medical professionals in the medical use of cannabis products so that more patients might benefit from this powerful medicine.

Website: www.aacmsite.org

Please contact AACM VP Frank Lucido, M.D. at (510) 848-0958 or AACM VP David Bearman, M.D. (805) 961-9988 for more information on clinical efficacy and/or to book radio or TV appearances.


Who's Who in Medical Cannabis - Dr. Raphael Mechoulam, Ph.D


Political controversy over medical marijuana is widespread in the United States, but clinical studies conducted abroad over the past forty-some years have revealed that marijuana, or cannabis, does indeed appear to have potent therapeutic qualities.

Widely regarded as one of the world's experts on cannabinoid-based medicine, and a member of the Israel Academy of Sciences, Dr. Raphael Mechoulam, Ph.D., Professor of Medicinal Chemistry at the Hebrew University of Jerusalem, along with his colleagues, has been researching what he calls "cannabinoid chemistry" over these past four decades, making many notable contributions to the field. Dr. Mechoulam has written countless scientific papers on his cannabinoid research results, as well as a review of his group's early studies, the book Cannabinoids as Therapeutic Agents.

Dr. Mechoulam has been awarded many honors for his groundbreaking work, including the highest national scientific prize in Israel-the Israel Prize. He is a past-president of the International Cannabinoid Research Society. Those who know Dr. Mechoulam describe him as mentally vigorous, generous and kind.

In 1964 Dr. Mechoulam and his associates identified and synthesized THC (delta-9-tetrahydrocannabinol), creating an entire new line of medical research. Twenty-eight years later, in 1992, working with Drs. William Devane and Lumir Hanus, Dr. Mechoulam identified the brain's natural version of THC, or endocannabinoid. The doctors named this natural THC "anandamide," from the Sanskrit, ananda, which is translated as "eternal bliss" or "supreme joy."

Research has revealed that the brain contains many cannabinoid neurotransmitters and receptors. The 1964 discovery of THC led to the eventual discovery of the endocannabinoid system in the brain. Further research conducted by Dr. Mechoulam, working with Dr. Lumir Hanus and Dr. Shimon Ben-Shabat, has led to the detection of an additional endocannabinoid with the tongue-twisting name 2-arachidonylglycerol, or 2-AG. As a result of this work, understanding of cannabinoid systems has advanced significantly.

Endocannabinoids are part of the brain's reward system, helping with the reduction of pain, regulation of emotions, consolidation of memory and the synchronization of movement. Interestingly, cannabinoid receptors outnumber all other receptors in the brain; the endocannabinoid system is active in nearly every other physiological system that has been studied. Therefore, Dr. Mechoulam has concluded that the endocannabinoid system is crucial to communication with and functions of many other bodily systems.

Pharmaceutical companies in the UK and France are researching and developing many new cannabis-based medicines. Carefully conducted trials have shown not only pain-relieving action and growth-retardation in tumors, but efficacy in treating multiple sclerosis and seizure disorders and a host of other medical conditions.

Over just the past few years the pace of cannabinoid research has been steadily increasing. Quite promising are new drugs currently being developed that both activate and deactivate cannabinoid receptors in the brain. Pain management, neuroprotective treatment for head trauma and stroke, and appetite regulation are just a few of the applications now being studied.

Most recently, one of the synthetic compounds (HU-211) from Dr. Mechoulam's lab has completed phase 2 clinical trials against head trauma with evidence of a neuroprotective effect. The pace of cannabinoid research has certainly been accelerating over the past few years, and Dr. Mechoulam thinks these new drugs are just the tip of the iceberg.

Learn more about Dr. Raphael Mechoulam and his outstanding accomplishments for medical cannabis patients. See David Jay Brown's full report on his interview with Dr. Mechoulam, on which this article is based, at http://mavericksofthemind.com/dr-raphael-mechoulam.


What's New


Illinois: Considering a medical marijuana law.

New Hampshire: Some state legislators are considering a medical marijuana law.

New Jersey: Considering a medical marijuana law.

New York: Considering a medical marijuana law.

North Carolina: Considering a medical marijuana law.

Ohio: Considering a medical marijuana law.

Pennsylvania: Considering a medical marijuana law.

Wisconsin: Considering a medical marijuana law.


Featured Recipe - Basic Bud Brownies by Jay R. Cavanaugh, PhD


The brownie has to go down in history as the classic Cannabis yummy. Anyone remember "I Love You Alice B. Toklas"? Yikes, weíre showing our age again.

During my student days at Berkeley in the 60ís, I was introduced to brownies and chocolate chip cookies that frankly were dreadful. These were the days when one simply dropped half a bag of the local leaf into the brownie mix. Ugh! I know some readers like the taste of Cannabis and while there are some strains that are a bit tasty most Cannabis tastes pretty rotten in an unprocessed state. Patients who require Cannabis food products are often already having a tough time keeping things down so the food should be appetizing, tasty, and go easy on the stomach. Hereís a powerful basic brownie recipe where you wonít be picking stems from your teeth. Proceed with caution. Diabetics beware!

Ingredients:

3 ounces unsweetened chocolate
4 tablespoons unsweetened dairy butter-flaked into pieces
4 tablespoons better bud butter (or kief butter)-flaked into pieces
1\2 teaspoon double acting baking powder
3\4 cup regular flour-sifted
A pinch of salt
2 large eggs
1 cup of sugar (plain white granulated)
1-teaspoon vanilla extract (the real deal not the "flavor")
1 cup chopped pecans (you may substitute walnuts, hazelnuts, almonds, or macadamias)

Optional- 1 tablespoon Grand Marnier or if youíre using almonds, Amaretto

Directions:

Preheat the oven to 350 degrees. Butter and lightly flour dust an eight-inch baking pan. Melt the chocolate and butters together in a saucepan using low heat and constant stirring. Once smooth set the chocolate aside to completely cool.

Sift together the flour, baking powder, and salt into a mixing bowl. In a separate bowl beat the eggs with a mixer while slowly adding the sugar. Mix until clear and pale in color. Pour in the chocolate/butter and vanilla with constant stirring. Slowly blend in the flour and the liquor. Last, but not least, add the nuts. Bake at 350 degrees for 25-30 minutes (less time is chewier and more time is drier). Heck, some of us just eat the mix. After baking, cool the brownies and cut into 12-16 squares (personally, I like triangles).

Each brownie is going to contain approximately 1\4 to 1\3 tablespoon of better bud butter. This is potent. Itís also very delicious. Do not operate heavy machinery or drive.

Recommended beverage: Morning time tea or coffee is a great accompaniment. I prefer Earl Grey tea or Guatemalan Antigua coffee. If the brownies are served after dinner, then once again coffee can be served or a desert wine like a good tawny Port. Be careful mixing alcohol with these potent brownies though, it can make ones stomach a bit upset.

From this basic recipe you can create literally hundreds of variations. Try glazing the brownies or sprinkling powdered sugar and raspberries on top.



Follow AAMC on:
http://apps.facebook.com/causes/162496
Don't miss the
6th National Clinical Conference on Cannabis Therapeutics
April 15-17, 2010
Providence, RI USA



Medical Marijuana States

Alaska
California
Colorado
Hawaii
Maine
Michigan
Montana
Nevada
New Mexico
Oregon
Rhode Island
Vermont
Washington